Enacts the manufacturer disclosure and transparency act

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 4 Sponsors

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Chamber: House
Introduced: Jan 16, 2025
Last action: Jan 7, 2026 — REFERRED TO CONSUMER AFFAIRS AND PROTECTION
Session: 2025-2026
Momentum: 58 · Moderate

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Amended — base rate 13%, measured from NY's completed sessions
Momentum +2 58/100 from the pace of recorded action
Time since last action -22 287 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.